Initial findings from the APPG reveal that 65% of the STEM workforce are White men. The STEM workforce also has a lower share of both female workers (27% vs. 52%) and disabled workers (11% vs. 14%) compared to the overall UK workforce. The APPG are calling on the STEM sector, and those in pharma specifically, to respond to their Call for Evidence in order to gain a representative view of the environment and culture of UK STEM workplaces, and inform recommendations to Government in their subsequent report
11 December, 2020
OVO Biomanufacturing, a spin-out from the University of Warwick and Coventry University, is developing digital solutions to improve the efficiency of viral vaccine and gene therapy manufacture. OVO’s technology allows manufacturers of both established and novel viral vaccines and gene therapies to maximise the production of the target virus used to produce each therapy. The technology can be applied to any virus that is grown to produce a vaccine or therapy. Improving the efficiency of manufacture can improve yield, cut lead times and costs and maximise distribution, which is essential for current and future pandemics.
05 December, 2020
Sanyou signs two commercial-use licenses for Horizon’s gene-edited CHO-K1 GS knockout cell line, for use in biotherapeutic pipeline development and contract research services
02 December, 2020
Bora Pharmaceuticals Co., Ltd announced today that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK’s Mississauga, Ontario (Canada) facility
01 December, 2020